A diagnostic test for Multiple Myeloma Drugs Development Market has been developed by the in vitro diagnostics company Sebia and the French pharmaceuticals company Sanofi. In Immunofixation Electrophoresis (IFE) tests, the test will reduce potential interference from Sanofi's investigational antibody, isatuximab. Isatuximab is a monoclonal antibody that targets a specific CD38 epitope and...